Try our Advanced Search for more refined results
Mylan NV
-
Filed: April 26, 2024 | Entered: April 26, 2024 Actelion Pharmaceuticals Ltd. et al v. Mylan Pharmaceuticals Inc.
835(Patent - Abbreviated New Drug Applications (ANDA)) | West Virginia Northern
Answer
ANSWER to 20 Amended Complaint by Mylan Pharmaceuticals Inc..(O'Brien, William) (Entered: 04/26/2024)
-
Motion | Filed: April 26, 2024 | Entered: April 26, 2024 Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc.
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Stipulation to EXTEND Time
STIPULATION TO EXTEND TIME to serve rebuttal expert reports to May 24, 2024 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis)
-
Misc | Filed: April 26, 2024 | Entered: April 26, 2024 SILBERSHER et al v. JANSSEN BIOTECH INC. et al
Qui Tam (31 U.S.C. § 3729(a)) | New Jersey
Letter
Letter from Jeffrey J. Greenbaum to Judge Douglas E. Arpert U.S.M.J. (Ret.). (Attachments: # 1 Exhibit A - Defendants' Dispute Letter, # 2 Exhibit B - Zytiga Defendants' Dispute Letter, # 3 Exhibit C - Zytiga Defendants' Dispute Letter)(GREENBAUM, JEFFREY)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login